CATALOGO DEI PRODOTTI DELLA RICERCA

GISONDI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.151
EU - Europa 5.819
AS - Asia 1.501
OC - Oceania 56
SA - Sud America 40
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.108
GB - Regno Unito 1.800
CN - Cina 1.251
IT - Italia 1.246
IE - Irlanda 632
FR - Francia 572
SE - Svezia 540
DE - Germania 366
FI - Finlandia 333
UA - Ucraina 119
TR - Turchia 67
AU - Australia 50
ES - Italia 40
IN - India 27
BE - Belgio 26
CA - Canada 24
NL - Olanda 24
BR - Brasile 22
SG - Singapore 22
KR - Corea 21
RU - Federazione Russa 20
PL - Polonia 19
IR - Iran 16
JP - Giappone 16
MX - Messico 16
CH - Svizzera 14
HK - Hong Kong 13
MY - Malesia 13
CZ - Repubblica Ceca 12
CL - Cile 10
DK - Danimarca 10
ID - Indonesia 8
RO - Romania 8
SA - Arabia Saudita 8
EG - Egitto 7
KZ - Kazakistan 7
TH - Thailandia 7
VN - Vietnam 7
DZ - Algeria 6
NZ - Nuova Zelanda 6
AT - Austria 5
IL - Israele 5
IS - Islanda 5
HR - Croazia 4
PT - Portogallo 4
CO - Colombia 3
EE - Estonia 3
EU - Europa 3
LK - Sri Lanka 3
MA - Marocco 3
NO - Norvegia 3
AL - Albania 2
EC - Ecuador 2
JO - Giordania 2
LU - Lussemburgo 2
LV - Lettonia 2
PK - Pakistan 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
OM - Oman 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 13.590
Salva come PNG Salva come JPEG
Città #
Southend 1.591
Chandler 1.055
Jacksonville 952
Dublin 621
Woodbridge 551
Ann Arbor 431
Houston 428
Ashburn 405
Beijing 223
Wilmington 220
Lawrence 215
Princeton 215
Jinan 131
Nanjing 129
New York 111
Shenyang 97
Sindelfingen 94
Milan 87
Verona 83
Rome 67
Helsinki 65
Hebei 63
Haikou 53
Washington 48
Seattle 46
Tianjin 46
Nanchang 44
Changsha 43
Redwood City 42
Guangzhou 37
Hangzhou 34
Zhengzhou 33
Jiaxing 32
Falls Church 29
Boardman 28
Bologna 28
Ningbo 28
Redmond 27
Brussels 25
Chicago 25
Esslingen am Neckar 25
Los Angeles 25
Fairfield 22
Taizhou 22
Norwalk 21
Venice 20
Seoul 19
Düsseldorf 17
Turin 17
Dongguan 16
Lancaster 16
Sydney 16
Florence 15
Fuzhou 15
Kuala Lumpur 13
Enfield 12
Madrid 12
Taiyuan 12
Brescia 11
Genoa 11
Phoenix 11
Atlanta 10
Frankfurt am Main 10
Toronto 10
Edinburgh 9
Lanzhou 9
London 9
Palermo 9
Perth 9
Shanghai 9
Vicenza 9
Canberra 8
Catania 8
Lappeenranta 8
Mersin 8
Singapore 8
Warsaw 8
Almaty 7
Bari 7
Copenhagen 7
Las Rozas de Madrid 7
Trieste 7
Amsterdam 6
Cairo 6
Casaloldo 6
Dallas 6
Dearborn 6
Hong Kong 6
Mexico City 6
Paris 6
Parma 6
Pomezia 6
Riyadh 6
Santiago 6
Tappahannock 6
Auburn Hills 5
Bientina 5
Clearwater 5
Frosinone 5
Kolkata 5
Totale 9.109
Salva come PNG Salva come JPEG
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 541
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 295
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 287
Dietary supplements for lipedema 168
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 103
Impact of TNF-α antagonists on the quality of life in selected skin diseases 100
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 99
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 99
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 97
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 97
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 96
Vitamin D levels in patients with psoriasis with or without arthritis 96
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 95
Squamous cell carcinoma arising in lupus vulgaris. 95
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 95
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 94
Polymorphisms, diet and nutrigenomics 92
Severe impairment of quality of life in Hailey-Hailey disease. 92
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 90
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 88
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 83
Lebbra lepromatosa. 81
Retention rate of systemic drugs in patients with chronic plaque psoriasis 81
The expectations of patients with psoriasis during an office consultation 81
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 80
Targeting TNF-a in psoriasis and psoriatic arthritis. 80
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 79
Heat urticaria: a revision of published cases with an update on classification and management 79
Pimecrolimus in dermatology: atopic dermatitis and beyond. 78
Incidence of respiratory and allergic symptoms in Italian and immigrant children 77
Attitude to treatment of patients with psoriasis attending SPA center 77
Advanced Glycation End Products in the Pathogenesis of Psoriasis 77
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. 76
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 76
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 76
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 74
Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study 74
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 74
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 74
Psoriasis and the metabolic syndrome 74
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 73
Acneiform eruption induced by cetuximab 73
Psoriasis, the liver, and the gastrointestinal tract 73
Psoriasi. Una guida per una migliore gestione del paziente. 72
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 72
The diagnostic and therapeutic challenge of early psoriatic arthritis 72
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. 71
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 71
The importance of treating mild atopic dermatitis. 70
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. 69
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 69
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 69
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 68
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 68
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 68
Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis 68
Il ruolo della vitamina D nella dermatite atopica 67
Chronic plaque psoriasis is associated with increased arterial stiffness 67
Complicanze dell'obesità: la cute 67
PSORIASIS 67
Effects of secukinumab on serum adipocytokines: preliminary data 67
Hyperuricaemia in patients with chronic plaque psoriasis. 67
Autoimmune progesterone dermatitis. 66
Dermatite atopica. 66
Insufficient knowledge among psoriasis patients can represent a barrier to participation in decision-making. 66
Metabolic comorbidities and psoriasis. 66
The metabolic syndrome in psoriasis 66
Image Gallery: Pyoderma gangrenosum of the penis. 66
Patients with psoriasis have a higher prevalence of parental cardiovascular disease 65
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008. 65
Psodisk, a new visual method for assessing the burden of psoriasis on patients. 64
Biologic therapies in psoriasis: a new therapeutic approach 64
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 64
Systemic therapy of psoriasis in diabetic patients 63
Targeting tumor necrosis factor a in the therapy of psoriasis. 63
Imiquimod: un ruolo nel trattamento topico della epidermodisplasia verruciforme? 62
Immunoregulation of allergic contact dermatitis. 61
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. 61
Microcircolatory modifications of psoriatic lesions during topical therapy. 61
Vitamin D status in patients with chronic plaque psoriasis 61
Le malattie della mucosa orale 61
Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab. 61
Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. 61
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 61
Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. 60
Usefulness of the Framingham risk score in patients with chronic psoriasis 60
L’organo pelle: struttura, biologia, funzioni. 59
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 58
Phenotypes of atopic dermatitis 57
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 57
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. 57
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 57
Aggiornamento sulla terapie biologiche della psoriasi 56
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 56
Concept of Remission in Chronic Plaque Psoriasis 56
Perception of disease and doctor-patient relationship experienced by patients with psoriasis. A questionnaire-based study 56
The need for long-term continuous therapy in moderate to severe chronic plaque psoriasis 55
La dermatite atopica nella seconda infanzia ed adolescenza 55
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry* 55
Public perception of dermatology and dermatologists in Italy: results from a population-based national survey 55
Totale 8.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.087
article - articoli 48.235
book - libri 201
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.651
Totale 100.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201943 0 0 0 0 0 0 0 0 0 0 13 30
2019/20201.438 197 28 23 120 104 206 142 98 104 147 98 171
2020/20211.571 130 295 66 168 199 198 42 100 100 27 184 62
2021/20221.439 86 230 38 121 88 91 54 109 79 55 125 363
2022/20233.859 269 238 357 605 270 889 66 195 503 213 182 72
2023/20241.970 119 198 241 282 262 403 149 158 35 110 13 0
Totale 13.912